Loading...
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Immune checkpoint blockade (ICB) therapies, which potentiate the body’s natural immune response against tumor cells, have shown immense promise in the treatment of various cancers. Currently, tumor mutational burden (TMB) and programmed death ligand 1 (PD-L1) expression are the primary biomarkers ev...
Na minha lista:
| Udgivet i: | Genome Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6264032/ https://ncbi.nlm.nih.gov/pubmed/30497521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-018-0605-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|